ANAHEIM, Calif.--(BUSINESS WIRE)--ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that cardiac critical care investigators presented data last week at the 62nd annual German Anesthesia Congress (DAC 2015) in Düsseldorf, Germany about outcomes in patients who develop Retained Blood Syndrome (RBS) from incomplete blood evacuation after cardiac surgery. Cardiac Anesthesia specialists from Charité University Hospital Berlin’s Department of Anesthesiology and


| < Prev | Next > |
|---|
